43
Participants
Start Date
April 4, 2019
Primary Completion Date
May 29, 2020
Study Completion Date
May 29, 2020
OTO-313
single intratympanic injection of gacyclidine
Placebo
single intratympanic injection of placebo
Northwell Health at ENT and Allergy Associates, White Plains
Summit Medical Group, Berkeley Heights
Northwell Health, Hearing & Speech Center, New Hyde Park
Dent Neurosciences Research Center, Amherst
WVU Medicine, Morgantown
Piedmont Ear, Nose, and Throat Associates, Winston-Salem
Charlotte Eye Ear Nose & Throat Associates, Charlotte
Silverstein Institute/Ear Research Foundation, Sarasota
Advanced ENT and Allergy, Louisville
ChicagoENT, Chicago
Tandem Clinical Research, LLC, Marrero
Worldwide Clinical Trials, San Antonio
Colorado ENT and Allergy, Colorado Springs
Chrysalis Clinical Research, St. George
House Clinic, Los Angeles
California Head & Neck Specialists, San Diego
Lead Sponsor
Otonomy, Inc.
INDUSTRY